Braude A I, Siemienski J S
J Clin Invest. 1968 Aug;47(8):1763-73. doi: 10.1172/JCI105866.
Dual urinary infections were produced in rats with colicinogenic Escherichia coli CF1, elaborating colicin V in the urine, and colicine-sensitive E. coli 9224 by injecting each organism into the medulla of opposite kidneys. The colicin-sensitive organism was eradicated from the urine of 24.3% of rats and the degree of infection by E. coli 9224 reduced to less than half of the control group. Colicin-resistant mutants of E. coli 9224 were not inhibited in mixed infections with colicin producing E. coli CF1. No evidence of inhibitory activity by colicin V was found in the kidneys. The bladder urine, but not the kidney, was also the site for transfer of colicinogeny between homologous (E. coli) and heterologous (E. coli and Aerobacter aerogenes) species. Episomes controlling colicin V and J + I were transferred within 24 hr after establishing the mixed infection. Since E. coli 9224 was resistant to streptomycin and tetracycline, observations were also made on transmission of multiple drug resistance. Streptomycin and tetracycline resistance was readily transferred to E. coli CF1 within 48 hr in the bladder. These results demonstrate that in urinary infections colicins can kill susceptible bacteria and that bacterial genetic elements are transferred.
将产大肠杆菌素的大肠杆菌CF1(在尿液中产生大肠杆菌素V)和对大肠杆菌素敏感的大肠杆菌9224分别注射到大鼠相对肾脏的髓质中,从而在大鼠中引发双重尿路感染。在24.3%的大鼠尿液中,对大肠杆菌素敏感的细菌被清除,大肠杆菌9224的感染程度降至对照组的一半以下。在与产大肠杆菌素的大肠杆菌CF1混合感染时,大肠杆菌9224的抗大肠杆菌素突变体未受到抑制。在肾脏中未发现大肠杆菌素V的抑制活性证据。膀胱尿液而非肾脏,也是同源(大肠杆菌)和异源(大肠杆菌和气杆菌)物种之间大肠杆菌素ogeny转移的部位。在建立混合感染后24小时内,控制大肠杆菌素V和J + I的附加体发生了转移。由于大肠杆菌9224对链霉素和四环素耐药,因此还对多重耐药性的传播进行了观察。在膀胱中,链霉素和四环素耐药性在48小时内很容易转移到大肠杆菌CF1。这些结果表明,在尿路感染中,大肠杆菌素可以杀死敏感细菌,并且细菌遗传元件会发生转移。